Study of the Neuroprotective Effects of Memantine in Patients with Mild to Moderate Ischemic Stroke

por Kafi, Hamidreza, Salamzadeh, Jamshid, Beladimoghadam, Nahid, Sistanizad, Mohammad, Kouchek, Mehran
Publicado 2014

Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva(®)) in Patients with Multiple Sclerosis: An Observational Retrospective Study

por Abolfazli, Roya, Sahraian, Mohammad Ali, Tayebi, Atefeh, Kafi, Hamidreza, Samadzadeh, Sara
Publicado 2023

Alvopem(®) (pemetrexed) safety assessment in patients with non-small cell lung cancer or malignant pleural mesothelioma: a post-marketing surveillance

por Seifi, Sharareh, Salimi, Babak, Monfared, Zahra Esfahani, Sabahi, Cyrus, Kafi, Hamidreza, Khosravi, Adnan
Publicado 2023

Evaluating the efficacy and safety of SpikoGen®, an Advax-CpG55.2–adjuvanted severe acute respiratory syndrome coronavirus 2 spike protein vaccine: a phase 3 randomized placebo-con...

por Tabarsi, Payam, Anjidani, Nassim, Shahpari, Ramin, Mardani, Masoud, Sabzvari, Araz, Yazdani, Babak, Kafi, Hamidreza, Fallah, Newsha, Ebrahimi, Ali, Taheri, Ali, Petrovsky, Nikolai, Barati, Saghar
Publicado 2023

Immunogenicity and Safety of SpikoGen, an Adjuvanted Recombinant SARS-CoV-2 Spike Protein, as a Heterologous Third Booster Dose in Kidney Transplant Patients: A Single-arm Clinical...

por Nafar, Mohsen, Mostafaloo, Narges, Firouzan, Ahmad, Poorrezagholi, Fatemeh, Samadian, Fariba, Dalili, Nooshin, Barati, Saghar, Anjidani, Nassim, Kafi, Hamidreza, Shahpari, Ramin, Bayat, Mahdiye, Kianipour, Soha, Samavat, Shiva
Publicado 2022

Efficacy and Safety of a Biosimilar Liraglutide (Melitide(®)) Versus the Reference Liraglutide (Victoza(®)) in People with Type 2 Diabetes Mellitus: A Randomized, Double-Blind, Non...

por Esteghamati, Alireza, Zamanzadeh, Mehran, Malek, Mojtaba, Khaledi, Mohammad, Monavari, Arezoo, Najafi, Laily, Banazadeh, Zahra, Malboosbaf, Ramin, Aghili, Rokhsareh, Mahdikhah, Sedigheh, Ganjizadeh-Zavereh, Hasan, Kafi, Hamidreza, Hosseinpanah, Farhad, Khamseh, Mohammad Ebrahim
Publicado 2023

A randomized, double-blind, phase III, non-inferiority clinical trial comparing the efficacy and safety of TA4415V (a proposed Trastuzumab biosimilar) and Herceptin (Trastuzumab re...

por Nodehi, Reza Safaei, Kalantari, Behjat, Raafat, Jahangir, Ansarinejad, Nafiseh, Moazed, Vahid, Mortazavizadeh, Seyed Mohammad Reza, Hosseinzadeh, Mehran, Ghaderi, Bayazid, Jenabian, Arash, Qadyani, Mojtaba, Haghighat, Shirin, Allahyari, Abolghasem, Mirzania, Mehrzad, Seghatoleslami, Mohammad, Payandeh, Mehrdad, Alikhasi, Afsaneh, Kafi, Hamidreza, Shahi, Farhad
Publicado 2022

Increasing the Number of Adverse Drug Reactions Reporting: the Role of Clinical Pharmacy Residents

por Baniasadi, Shadi, Habibi, Maryam, Haghgoo, Roodabeh, Karimi Gamishan, Masoumeh, Dabaghzadeh, Fatemeh, Farasatinasab, Maryam, Farsaei, Shadi, Gharekhani, Afshin, Kafi, Hamidreza, Karimzadeh, Iman, Kharazmkia, Ali, Najmeddin, Farhad, Nikvarz, Naemeh, Oghazian, Mohammad Bagher, Rezaee, Haleh, Sadeghi, Kourosh, Tafazzoli, Ali, Shahsavari, Nahid, Fahimi, Fanak
Publicado 2014

Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized, phase III, equivalency cl...

por Allahyari, Abolghasem, Ehsanpour, Ali, Ansarinejad, Nafiseh, Mehrzad, Valiollah, Kalantari, Behjat, Raafat, Jahangir, Ghadiany, Mojtaba, Shahi, Farhad, Gharib, Behrooz, Moazed, Vahid, Khosravi, Adnan, Mirpour, Mir Hossein, Salari, Sina, Mortazavizadeh, Seyedmohammadreza, Nekoyi, Amirabbas, Khani, Mohsen, Sadeghi, Alireza, Gharib, Sirus, Bary, Alireza, Mirzania, Mehrzad, Haghighat, Shirin, Razavi, Seyed Mohsen, Emami, Seyed Amir Hossein, Hosseinzadeh, Mehran, Mirbolouk, Mahdi, Sadighi, Sanambar, Shahrasbi, Abdolali, Esfahani, Ali, Gity, Masoumeh, Anjidani, Nassim, Kafi, Hamidreza, Najafi, Safa
Publicado 2022